Epigenetics: A new way to look at kidney diseases

Nephrology Dialysis Transplantation

Volumn 29, Issue 10, 2014, Pages 1821-1827

  Beckerman, Pazit ^a   Ko, Yi An ^a   Susztak, Katalin ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

chronic kidney disease; cytosine methylation; enhancers; epigenetics

Indexed keywords

ACTIVATION INDUCED CYTIDINE DEAMINASE; CYTOSINE; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; TRANSCRIPTION FACTOR;

CHRONIC KIDNEY DISEASE; CPG ISLAND; DEMETHYLATION; DIABETIC NEPHROPATHY; DNA METHYLATION; DNA REPLICATION; EMBRYO DEVELOPMENT; ENHANCER REGION; EPIGENETICS; HISTONE MODIFICATION; HUMAN; HUMAN GENOME; HYPERGLYCEMIA; HYPERTENSION; KIDNEY DISEASE; NEXT GENERATION SEQUENCING; NONHUMAN; PRIORITY JOURNAL; REVIEW; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; KIDNEY DISEASES;

DNA METHYLATION; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION; HUMANS; KIDNEY DISEASES;

EID: 84921778012     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfu026     Document Type: Review

References (45)

1. Ko YA, Susztak K. Epigenomics: the science of no-longer-junk DNA. Why study it in chronic kidney disease? Semin Nephrol 2013; 33: 354-362
2. Fratkin E, Bercovici S, Stephan DA. The implications of ENCODE for diagnostics. Nat Biotechnol 2012; 30: 1064-1065
3. Ernst J, Kellis M. Interplay between chromatin state, regulator binding, and regulatory motifs in six human cell types. Genome Res 2013; 23: 1142-1154
4. Neph S, Stergachis AB, Reynolds A et al. Circuitry and dynamics of human transcription factor regulatory networks. Cell 2012; 150: 1274-1286
5. Kouzarides T. Chromatin modifications and their function. Cell 2007; 128: 693-705
6. Dunham I, Kundaje A, Aldred SF et al. An integrated encyclopedia of DNA elements in the human genome. Nature 2012; 489: 57-74
7. Ernst J, Kheradpour P, Mikkelsen TS et al. Mapping and analysis of chromatin state dynamics in nine human cell types. Nature 2011; 473: 43-49
8. Maston GA, Landt SG, Snyder M et al. Characterization of enhancer function from genome-wide analyses. Annu Rev Genomics Hum Genet 2012; 13: 29-57
9. Inoki K, Mori H, Wang J et al. mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice. J Clin Invest 2011; 121: 2181-2196
10. Visel A, Blow MJ, Li Z et al. ChIP-seq accurately predicts tissue-specific activity of enhancers. Nature 2009; 457: 854-858
11. Heintzman ND, Hon GC, Hawkins RD et al. Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature 2009; 459: 108-112
12. Mohtat D, Susztak K. Fine tuning gene expression: the epigenome. Semin Nephrol 2010; 30: 468-476
13. Rhee I, Bachman KE, Park BH et al. DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature 2002; 416: 552-556
14. Ooi SK, Bestor TH. The colorful history of active DNA demethylation. Cell 2008; 133: 1145-1148
15. Ko M, Huang Y, Jankowska AM et al. Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2. Nature 2010; 468: 839-843
16. Cadet J, Wagner JR. TET enzymatic oxidation of 5-methylcytosine, 5-hydroxymethylcytosine and 5-formylcytosine. Mutat Res 2014; in press.
17. Vincent JJ, Huang Y, Chen PY et al. Stage-specific roles for tet1 and tet2 in DNA demethylation in primordial germ cells. Cell Stem Cell 2013; 12: 470-478
18. Williams K, Christensen J, Helin K. DNA methylation: TET proteinsguardians of CpG islands? EMBO Rep 2012; 13: 28-35
19. Williams K, Christensen J, Pedersen MT et al. TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelity. Nature 2011; 473: 343-348
20. Bartolomei MS. Epigenetics: role of germ cell imprinting. Adv Exp Med Biol 2003; 518: 239-245
21. Bestor TH. The DNA methyltransferases of mammals. Hum Mol Genet 2000; 9: 2395-2402
22. Challen GA, Sun D, Jeong M et al. Dnmt3a is essential for hematopoietic stem cell differentiation. Nat Genet 2012; 44: 23-31
23. Dodge JE, Okano M, Dick F et al. Inactivation of Dnmt3b in mouse embryonic fibroblasts results in DNA hypomethylation, chromosomal instability, and spontaneous immortalization. J Biol Chem 2005; 280: 17986-17991
24. Xie W, Schultz MD, Lister R et al. Epigenomic analysis of multilineage differentiation of human embryonic stem cells. Cell 2013; 153: 1134-1148
25. Hon GC, Rajagopal N, Shen Y et al. Epigenetic memory at embryonic enhancers identified in DNA methylation maps from adult mouse tissues. Nat Genet 2013; 45: 1198-1206
26. Ziller MJ, Muller F, Liao J et al. Genomic distribution and inter-sample variation of non-CpG methylation across human cell types. PLoS Genet 2011; 7: e1002389
27. Akopian V, Chan MM, Clement K et al. Epigenomics and chromatin dynamics. Genome Biol 2012; 13: 313
28. Ziller MJ, Gu H, Muller F et al. Charting a dynamic DNA methylation landscape of the human genome. Nature 2013; 500: 477-481
29. Kaaij LT, van de Wetering M, Fang F et al. DNA methylation dynamics during intestinal stem cell differentiation reveals enhancers driving gene expression in the villus. Genome Biol 2013; 14: R50
30. Hodges E, Molaro A, Dos Santos CO et al. Directional DNA methylation changes and complex intermediate states accompany lineage specificity in the adult hematopoietic compartment. Mol Cell 2011; 44: 17-28
31. Maunakea AK, Chepelev I, Cui K et al. Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition. Cell Res 2013; 23: 1256-1269
32. Shukla S, Kavak E, Gregory M et al. CTCF-promoted RNA polymerase II pausing links DNA methylation to splicing. Nature 2011; 479: 74-79
33. O'Sullivan L, Little MH, Combes AN et al. Epigenetics and developmental programming of adult onset diseases. Pediatr Nephrol 2012; 27: 2175-2182
34. Bjornsson HT, Brown LJ, Fallin MD et al. Epigenetic specificity of loss of imprinting of the IGF2 gene in Wilms tumors. J Natl Cancer Inst 2007; 99: 1270-1273
35. Davison JM, Mellott TJ, Kovacheva VP et al. Gestational choline supply regulates methylation of histone H3, expression of histone methyltransferases G9a (Kmt1c) and Suv39h1 (Kmt1a), and DNA methylation of their genes in rat fetal liver and brain. J Biol Chem 2009; 284: 1982-1989
36. Rakyan VK, Preis J, Morgan HD et al. The marks, mechanisms and memory of epigenetic states in mammals. Biochem J 2001; 356: 1-10
37. Cropley JE, Suter CM, Beckman KB et al. Germ-line epigenetic modification of the murine Avy allele by nutritional supplementation. Proc Natl Acad Sci USA 2006; 103: 17308-17312
38. Susztak K. Understanding the epigenetic syntax for the genetic alphabet in the kidney. J Am Soc Nephrol 2014; 25: 10-17
39. Hoppe CC, Evans RG, Bertram JF et al. Effects of dietary protein restriction on nephron number in the mouse. Am J Physiol Regul Integr Comp Physiol 2007; 292: R1768-R1774
40. De Boer IH, Rue TC, Cleary PA et al. Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the diabetes control and complications trial/epidemiology of diabetes interventions and complications cohort. Arch Intern Med 2011; 171: 412-420
41. Sapienza C, Lee J, Powell J et al. DNA methylation profiling identifies epigenetic differences between diabetes patients with ESRD and diabetes patients without nephropathy. Epigenetics 2011; 6: 20-28
42. Bechtel W, McGoohan S, Zeisberg EM et al. Methylation determines fibroblast activation and fibrogenesis in the kidney. Nat Med 2010; 16: 544-550
43. Ko YA MD, Suzuki M, Park1 ASD et al. Cytosine methylation changes of enhancer regions of core pro-fibrotic genes characterize kidney fibrosis development. Genome Biol 2013; 14: R108
44. Dressler GR, Deutsch U, Chowdhury K et al. Pax2, a new murine pairedbox-containing gene and its expression in the developing excretory system. Development 1990; 109: 787-795
45. Woroniecka KI, Park AS, Mohtat D et al. Transcriptome analysis of human diabetic kidney disease. Diabetes 2011; 60: 2354-2369